Sanofi

Latest stories

3h
Namibia Economist
Low pressure(a negative interest rate) to hold cash reserves. This through-the-looking-glas
Low pressure
Namibia Economist / Posted 3 hours ago
(a negative interest rate) to hold cash reserves. This through-the-looking-glass practice has spread to capital markets. Sanofi, a French drugmaker, and Henkel, a German manufacturer of detergent, both this month issued bonds denominated in euros... Read more
2 related stories
3h
Reuters
Sanofi may win U.S. approval of $3 billion eczema drug by MarchFrench multinational pharmaceutical company SANOFI logo is seen at the headquar
Sanofi may win U.S. approval of $3 billion eczema drug by March
Reuters / Posted 3 hours ago
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo French drugmaker Sanofi (SASY.PA) and its U.S. partner Regeneron Pharmaceuticals (REGN.O) could... Read more
4h
Channel NewsAsia
Sanofi may win US approval of US$3 billion eczema drug by MarchREUTERS: French drugmaker Sanofi and its U.S. partner Regeneron Pharmaceuticals
Sanofi may win US approval of US$3 billion eczema drug by March
Channel NewsAsia / Posted 4 hours ago
REUTERS: French drugmaker Sanofi and its U.S. partner Regeneron Pharmaceuticals could win U.S. approval for their keenly awaited new eczema drug dupilumab, seen by analysts as a potential US$3 billion-a-year seller, by next March. Sanofi badly needs... Read more
6h
The Middletown Press
CT startups edge into cluttered market with diabetes appsdLife’s Diabetes Companion, Glucose Buddy from SkyHealth, iDiabetes from iHealt
CT startups edge into cluttered market with diabetes apps
The Middletown Press / Posted 6 hours ago
dLife’s Diabetes Companion, Glucose Buddy from SkyHealth, iDiabetes from iHealth Ventures, Track3 from Coheso, GoMeals from Sanofi-Aventis, and One Drop from Informed Data Systems. Some apps are downloadable at no cost, but others are priced from... Read more
3 related stories
6h
SiliconIndia
Indian Drug Formulation Market Grows 15.3 Pct In Augagainst 9% growth for MNC pharma companies during the month. Amongst the top 5
Indian Drug Formulation Market Grows 15.3 Pct In Aug
SiliconIndia / Posted 6 hours ago
against 9% growth for MNC pharma companies during the month. Amongst the top 50 MNCs, Janssen grew by 23.2% followed by Sanofi at 13.4% and Abbott at 12.6% over the same month last year. Among the top 50 Indian corporates, Centaur had the... Read more
7h
Stamford Advocate
Conn. startups focus on diabetes appsdLife’s Diabetes Companion, Glucose Buddy from SkyHealth, iDiabetes from iHealt
Conn. startups focus on diabetes apps
Stamford Advocate / Posted 7 hours ago
dLife’s Diabetes Companion, Glucose Buddy from SkyHealth, iDiabetes from iHealth Ventures, Track3 from Coheso, GoMeals from Sanofi-Aventis, and One Drop from Informed Data Systems. Some apps are downloadable at no cost, but others are priced from... Read more
3 related stories
7h
Connecticut Post
Conn. startups focus on diabetes appsdLife’s Diabetes Companion, Glucose Buddy from SkyHealth, iDiabetes from iHealt
Conn. startups focus on diabetes apps
Connecticut Post / Posted 7 hours ago
dLife’s Diabetes Companion, Glucose Buddy from SkyHealth, iDiabetes from iHealth Ventures, Track3 from Coheso, GoMeals from Sanofi-Aventis, and One Drop from Informed Data Systems. Some apps are downloadable at no cost, but others are priced from... Read more
3 related stories
8h
San Antonio Express-News
Conn. startups focus on diabetes appsdLife’s Diabetes Companion, Glucose Buddy from SkyHealth, iDiabetes from iHealt
Conn. startups focus on diabetes apps
San Antonio Express-News / Posted 8 hours ago
dLife’s Diabetes Companion, Glucose Buddy from SkyHealth, iDiabetes from iHealth Ventures, Track3 from Coheso, GoMeals from Sanofi-Aventis, and One Drop from Informed Data Systems. Some apps are downloadable at no cost, but others are priced from... Read more
3 related stories
16h
Business Standard India
Fund flows to emerging markets will continue: Vineet Bhatnagarend of calendar year 2016 (CY16) or beginning of 2017, but monetary policy will
Fund flows to emerging markets will continue: Vineet Bhatnagar
Business Standard India / Posted 16 hours ago
end of calendar year 2016 (CY16) or beginning of 2017, but monetary policy will remain accommodative. Recently, Henkel and Sanofi, two private companies, issued medium-term bonds with yield to maturity of minus 0.05 per cent. These are quite clear... Read more
23h
The Scranton Times-Tribune
Places to go and things to do in Northeast Pa.Commonwealth Medical College Scholarship Gala — Black Ties for White Coats, Oct
Places to go and things to do in Northeast Pa.
The Scranton Times-Tribune / Posted 23 hours ago
Commonwealth Medical College Scholarship Gala — Black Ties for White Coats, Oct. 15, 5:30 to 11:30 p.m. Patrick J. Solano, Sanofi Pasteur, L. Peter Frieder Jr., L. P. Frieder III and Gentex Corp. will be honored. $175. Mohegan Sun Pocono, Plains... Read more
97 related stories
1d
Business Standard India
Indian drug formulation market grows 15.3% in Augdata compiled by pharma market research company AIOCD AWACS. Amongst the top 5
Indian drug formulation market grows 15.3% in Aug
Business Standard India / Posted yesterday
data compiled by pharma market research company AIOCD AWACS. Amongst the top 50 MNCs, Janssen grew by 23.2% followed by Sanofi at 13.4% and Abbott at 12.6% over the same month last year. Among the top 50 Indian corporates, Centaur had the... Read more
1d
Business Wire
Alnylam Reports Positive Initial Results from Ongoing Phase 1/2 Study of ALN-GO1, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1and efficacy of ALN-GO1 have not been evaluated by the U.S. Food and Drug Admin
Alnylam Reports Positive Initial Results from Ongoing Phase 1/2 Study of ALN-GO1, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1
Business Wire / Posted yesterday
and efficacy of ALN-GO1 have not been evaluated by the U.S. Food and Drug Administration or any other health authority. Sanofi Genzyme AllianceIn January 2014, Alnylam and Sanofi Genzyme, the specialty care global business unit of Sanofi, formed... Read more
1d
Zero Hedge
How Much Longer Will Investors Trust The Central Banks?week the credit bubble entered new territory with two euro zone issuers of corp
How Much Longer Will Investors Trust The Central Banks?
Zero Hedge / Posted yesterday
week the credit bubble entered new territory with two euro zone issuers of corporate debt, Germany’s Henkel and France’s Sanofi, becoming the first private firms to sell negative-yielding non-financial corporate bonds in euros. This may, just... Read more
1d
FOX Business
Biotech Stocks Under $5: 2 To Buy, 1 To Avoidlung-function tests, which resulted in unexpectedlypoor sales. In turn, MannKin
Biotech Stocks Under $5: 2 To Buy, 1 To Avoid
FOX Business / Posted yesterday
lung-function tests, which resulted in unexpectedlypoor sales. In turn, MannKind's marketing partner for Afrezza, Sanofi, decided to terminate its marketing agreement earlier this year. Image Source: MannKind Corp. As it now stands,... Read more
1d
FOX Business
Ziopharm Oncology, Inc. Vs. Alnylam Pharmaceuticals, Inc.of the amendment. Through the years, Alnylam has partnered with multiple large
Ziopharm Oncology, Inc. Vs. Alnylam Pharmaceuticals, Inc.
FOX Business / Posted yesterday
of the amendment. Through the years, Alnylam has partnered with multiple larger companies. One key relationship is with Sanofi's (NYSE: SNY) Genzyme division. The two companies formed an alliance back in 2012 to develop and market ATTR... Read more
1d
FOX Business
Ziopharm Oncology, Inc. Vs. Alnylam Pharmaceuticals, Inc.of the amendment. Through the years, Alnylam has partnered with multiple large
Ziopharm Oncology, Inc. Vs. Alnylam Pharmaceuticals, Inc.
FOX Business / Posted yesterday
of the amendment. Through the years, Alnylam has partnered with multiple larger companies. One key relationship is with Sanofi's (NYSE: SNY) Genzyme division. The two companies formed an alliance back in 2012 to develop and market ATTR... Read more
2d
The Hindu
Sun Pharma signs deal to develop dengue vaccineare in various stages of development and commercial release. The most advanced
Sun Pharma signs deal to develop dengue vaccine
The Hindu / Posted 2 days ago
are in various stages of development and commercial release. The most advanced is Dengvaxia, developed by French drug maker Sanofi and recommended for use since December last in Brazil, Mexico, Philippines and El Salvador for those 9-45 years... Read more
2d
The Scranton Times-Tribune
TGIF: Your guide to area entertainment and eventsCommonwealth Medical College Scholarship Gala — Black Ties for White Coats, Oct
TGIF: Your guide to area entertainment and events
The Scranton Times-Tribune / Posted 2 days ago
Commonwealth Medical College Scholarship Gala — Black Ties for White Coats, Oct. 15, 5:30 to 11:30 p.m. Patrick J. Solano, Sanofi Pasteur, L. Peter Frieder Jr., L. P. Frieder III and Gentex Corp. will be honored. $175. Mohegan Sun Pocono, Plains... Read more
97 related stories
3d
FOX News
Hard To Swallow: Emerging Markets Get Tougher For Drugmakersmature markets by 2 to 3 percentage points," Olivier Charmeil, who heads up eme
Hard To Swallow: Emerging Markets Get Tougher For Drugmakers
FOX News / Posted 3 days ago
mature markets by 2 to 3 percentage points," Olivier Charmeil, who heads up emerging markets operations at French drugmaker Sanofi, told Reuters. GlaxoSmithKline's incoming chief executive Emma Walmsley, meanwhile, highlighted the potential of... Read more
2 related stories
3d
Channel NewsAsia
Hard to swallow: emerging markets get tougher for drugmakersmature markets by 2 to 3 percentage points," Olivier Charmeil, who heads up eme
Hard to swallow: emerging markets get tougher for drugmakers
Channel NewsAsia / Posted 3 days ago
mature markets by 2 to 3 percentage points," Olivier Charmeil, who heads up emerging markets operations at French drugmaker Sanofi, told Reuters. GlaxoSmithKline's incoming chief executive Emma Walmsley, meanwhile, highlighted the potential of... Read more
2 related stories
3d
Reuters
Hard to swallow: emerging markets get tougher for drugmakersmature markets by 2 to 3 percentage points," Olivier Charmeil, who heads up eme
Hard to swallow: emerging markets get tougher for drugmakers
Reuters / Posted 3 days ago
mature markets by 2 to 3 percentage points," Olivier Charmeil, who heads up emerging markets operations at French drugmaker Sanofi, told Reuters. GlaxoSmithKline's incoming chief executive Emma Walmsley, meanwhile, highlighted the potential of... Read more
2 related stories
3d
The Scranton Times-Tribune
Weekend Entertainment GuideCommonwealth Medical College Scholarship Gala — Black Ties for White Coats, Oct
Weekend Entertainment Guide
The Scranton Times-Tribune / Posted 3 days ago
Commonwealth Medical College Scholarship Gala — Black Ties for White Coats, Oct. 15, 5:30 to 11:30 p.m. Patrick J. Solano, Sanofi Pasteur, L. Peter Frieder Jr., L. P. Frieder III and Gentex Corporation will be honored. Tickets are $175. Mohegan Sun... Read more
97 related stories
4d
Business Insider
10 things you need to know before the opening bellsome brand-name drugs. The largest US health insurer says it will stop coverage
10 things you need to know before the opening bell
Business Insider / Posted 4 days ago
some brand-name drugs. The largest US health insurer says it will stop coverage of Lantus, the main insulin drug sold by Sanofi SA, and Amgen's white-blood-cell-boosting drug Neupogen, Reuters reports. Yahoo will confirm a historic hack.... Read more
4d
Business Wire
EVOTEC GIBT ONKOLOGIE-FORSCHUNGS-KOOPERATION MIT INSERM BEKANNTDeutschland und UK eingegangen. Die Zusammenarbeit mit Inserm stellt das erste
EVOTEC GIBT ONKOLOGIE-FORSCHUNGS-KOOPERATION MIT INSERM BEKANNT
Business Wire / Posted 4 days ago
Deutschland und UK eingegangen. Die Zusammenarbeit mit Inserm stellt das erste Projekt der Academic Bridge von Evotec und Sanofi dar, das im Rahmen der strategischen Allianz der beiden Unternehmen vom 01. April 2015 ins Leben gerufen wurde. Die... Read more
607 related stories
4d
Business Wire
Evotec Enters into a Research Collaboration with Inserm in Oncologyin the USA, Germany and the UK. This collaboration with Inserm marks the initia
Evotec Enters into a Research Collaboration with Inserm in Oncology
Business Wire / Posted 4 days ago
in the USA, Germany and the UK. This collaboration with Inserm marks the initiation of the first project under Evotec's and Sanofi's Academic Bridge, which was established as a result of the multi-component strategic alliance between the companies... Read more
4d
Business Wire
Takeda et Affilogic signent un accord de collaboration de recherche pour développer des thérapies à base de Nanofitin® ciblant le système nerveux centralcellules entières). Les médicaments à base de Nanofitin® sont actuellement en c
Takeda et Affilogic signent un accord de collaboration de recherche pour développer des thérapies à base de Nanofitin® ciblant le système nerveux central
Business Wire / Posted 4 days ago
cellules entières). Les médicaments à base de Nanofitin® sont actuellement en cours de développement en collaboration avec Sanofi, Ferring Pharmaceuticals et d'autres sociétés pharmaceutiques non divulguées. Plusieurs programmes au stade précoce... Read more
123 related stories
4d
NBC News
Mylan CEO defends epic EpiPen price hike in senate hearingchief competitor, Auvi-Q, to withdraw from the market in 2015, Mylan has enjoye
Mylan CEO defends epic EpiPen price hike in senate hearing
NBC News / Posted 4 days ago
chief competitor, Auvi-Q, to withdraw from the market in 2015, Mylan has enjoyed a de facto monopoly. Since Auvi-Q's maker Sanofi introduced it in 2013, the two had charged similar prices and raised them by similar amounts. "Mylan has dramatically... Read more
17 related stories
4d
Newsmax
Cholesterol Drug Reduces Arterial Plaque Buildupof "bad" LDL cholesterol. The new medicines have a list price of more than $14,
Cholesterol Drug Reduces Arterial Plaque Buildup
Newsmax / Posted 4 days ago
of "bad" LDL cholesterol. The new medicines have a list price of more than $14,000 a year. Regeneron Pharmaceuticals and Sanofi sell a rival drug called Praluent. They are far more expensive than statins, which are almost all now available in... Read more
5d
Business Wire
Takeda and Affilogic enter into Research Collaboration to Develop Nanofitin®-based Therapies in Central Nervous System(Virus-like Particles, bacteria, whole cells). Nanofitin®-based drugs are curre
Takeda and Affilogic enter into Research Collaboration to Develop Nanofitin®-based Therapies in Central Nervous System
Business Wire / Posted 5 days ago
(Virus-like Particles, bacteria, whole cells). Nanofitin®-based drugs are currently being developed in collaboration with Sanofi, Ferring Pharmaceuticals and other undisclosed pharmaceutical companies. Several early-stage programs are currently... Read more
5d
Boston Globe
Sarepta is now one of the hottest stars in Kendall Squareconsistent with that of other rare-disease drugs, such as treatments by Vertex
Sarepta is now one of the hottest stars in Kendall Square
Boston Globe / Posted 5 days ago
consistent with that of other rare-disease drugs, such as treatments by Vertex Pharmaceuticals Inc. for cystic fibrosis and Sanofi Genzyme for Gaucher disease. The medicine will be discounted for patients on Medicaid and covered by commercial health... Read more
109 related stories
5d
Pilipino Star
Losing steam in the war vs denguethe country was only second on the record, next to Mexico, to issue license to
Losing steam in the war vs dengue
Pilipino Star / Posted 5 days ago
the country was only second on the record, next to Mexico, to issue license to the vaccine manufactured by French-based Sanofi Pasteur. The French company first launched the only dengue vaccination program in April 2016. Last August, Brazil and... Read more
5d
Business Standard India
Cipla, Wockhardt join global initiative on tackling drug resistant infectionsthe companies said in a joint statement today. Other companies participating i
Cipla, Wockhardt join global initiative on tackling drug resistant infections
Business Standard India / Posted 5 days ago
the companies said in a joint statement today. Other companies participating in the initiative include Allergan, AstraZeneca, DSM Sinochem Pharmaceuticals, Roche, GSK Pharma, Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi... Read more
34 related stories
5d
Business Insider
A group of drug companies just laid out a plan to combat superbugsthe World Economic Forum in Davos, Switzerland. The pharma companies include m
A group of drug companies just laid out a plan to combat superbugs
Business Insider / Posted 5 days ago
the World Economic Forum in Davos, Switzerland. The pharma companies include major players like Johnson & Johnson, Pfizer, Sanofi, AstraZeneca, GlaxoSmithKline and Novartis. As part of the 2020 plan, the companies said they would: Make sure only... Read more
5d
Swissinfo
Glaxo's New CEO Ticks All But One Box. Science Is Optional: Gadfly16 times forecast earnings, in line with European peers Novartis, Roche and Ast
Glaxo's New CEO Ticks All But One Box. Science Is Optional: Gadfly
Swissinfo / Posted 5 days ago
16 times forecast earnings, in line with European peers Novartis, Roche and AstraZeneca, and a notable premium to Sanofi and Bayer. There's no rush. But if Glaxo's performance cannot be improved within the current structure, allowing... Read more
57 related stories
6d
Arkansas Democrat-Gazette
Stocks seesaw, close day with a lossor 1.4 percent, to $37.16. Health care stocks also lagged. Merck fell 95 cents
Stocks seesaw, close day with a loss
Arkansas Democrat-Gazette / Posted 6 days ago
or 1.4 percent, to $37.16. Health care stocks also lagged. Merck fell 95 cents, or 1.5 percent, to $61.33 after rival Sanofi said it was suing the company. Sanofi says Merck infringed on patents protecting the insulin drug Lantus. Eye-drug... Read more
8 related stories
6d
Boston Globe
US stocks end day mostly lowerlast week to its highest price this year, lost 1.2 percent, and Intel fell 1.4
US stocks end day mostly lower
Boston Globe / Posted 6 days ago
last week to its highest price this year, lost 1.2 percent, and Intel fell 1.4 percent. Merck fell 1.5 percent after rival Sanofi said it sued company, alleging patent violations. Isle of Capri Casinos agreed to be bought by Eldorado Resorts for... Read more
184 related stories
6d
KFDA-TV Amarillo
US stocks can't hang onto gains, finish lowerpercent, to $37.16. Health care stocks also lagged the market. Merck fell 95 c
US stocks can't hang onto gains, finish lower
KFDA-TV Amarillo / Posted 6 days ago
percent, to $37.16. Health care stocks also lagged the market. Merck fell 95 cents, or 1.5 percent, to $61.33 after rival Sanofi said it sued company. Sanofi says Merck infringed on patents protecting its insulin drug Lantus. Eye drug maker... Read more
8 related stories
6d
FOX News
Indonesia Begins Re-vaccinating Victims Of Fake Drug Ringused stolen vials and forged labels to make the fake medicine look like importe
Indonesia Begins Re-vaccinating Victims Of Fake Drug Ring
FOX News / Posted 6 days ago
used stolen vials and forged labels to make the fake medicine look like imported vaccines produced by GlaxoSmithKline and Sanofi. State-owned Bio Farma produces nearly all vaccines available in Indonesia. The syndicate sold fake booster vaccines... Read more
7d
Market Watch
Sanofi files patent suit against MerckPARIS-- Sanofi SA said it filed a lawsuit against Merck & Co. for alleged paten
Sanofi files patent suit against Merck
Market Watch / Posted 7 days ago
PARIS-- Sanofi SA said it filed a lawsuit against Merck & Co. for alleged patent infringements to prevent the U.S. drugmaker from launching a rival version of the French pharmaceutical giant's best-selling diabetes treatment Lantus. In the filing in... Read more
7d
Times of Malta
ETFs with a different geographical focusincome received to shareholders. The top five holdings in the index include To
ETFs with a different geographical focus
Times of Malta / Posted 7 days ago
income received to shareholders. The top five holdings in the index include Total SA, Anheuser-Busch InBev SA, Siemens AG, Sanofi and Bayer AG. Together representing 22% of in index. iShares Core FTSE 100 UCITS ETF (Geographical focus:... Read more
2 related stories
7d
Market Watch
Sanofi files U.S. suit against Merck over patentsPARIS--French pharmaceutical giant Sanofi SA (SAN.FR) Monday said it filed a la
Sanofi files U.S. suit against Merck over patents
Market Watch / Posted 7 days ago
PARIS--French pharmaceutical giant Sanofi SA (SAN.FR) Monday said it filed a lawsuit against Merck & Co.'s international unit for alleged patent infringements. In the filing in the U.S. district court of Delaware, Sanofi said it claims that Merck... Read more
7d
The Daily Reckoning
Negative Interest Rates: A Sure Sign the Economy Is Doomedour ace researcher, Nick Rokke. ‘On Tuesday, German household-products giant H
Negative Interest Rates: A Sure Sign the Economy Is Doomed
The Daily Reckoning / Posted 7 days ago
our ace researcher, Nick Rokke. ‘On Tuesday, German household-products giant Henkel and French pharmaceutical company Sanofi issued a total of €1.5 billion ($1.7 billion) of new bonds at yields of minus 0.05%.’ Nick might have added an... Read more
8d
The Clarion-Ledger
High insulin costs hit Mississippianscosts are rising. One exception has been the widely used long-acting form of in
High insulin costs hit Mississippians
The Clarion-Ledger / Posted 8 days ago
costs are rising. One exception has been the widely used long-acting form of insulin called Lantus, which is marketed by Sanofi. The drugmaker has been encountering pushback form insurers, and so the unit cost for the medicine fell nearly 14... Read more
8d
Stamford Advocate
There's something odd about the way insulin prices change— something that's been referred to as "shadow pricing." At least three compan
There's something odd about the way insulin prices change
Stamford Advocate / Posted 8 days ago
— something that's been referred to as "shadow pricing." At least three companies — Eli Lilly & Co., Novo Nordisk, and Sanofi Aventis — make and sell insulin. Despite this competition, prices have steadily climbed over the past decade, taking... Read more
7 related stories
8d
Connecticut Post
There's something odd about the way insulin prices change— something that's been referred to as "shadow pricing." At least three compan
There's something odd about the way insulin prices change
Connecticut Post / Posted 8 days ago
— something that's been referred to as "shadow pricing." At least three companies — Eli Lilly & Co., Novo Nordisk, and Sanofi Aventis — make and sell insulin. Despite this competition, prices have steadily climbed over the past decade, taking... Read more
7 related stories
8d
San Francisco Chronicle
There's something odd about the way insulin prices change— something that's been referred to as "shadow pricing." At least three compan
There's something odd about the way insulin prices change
San Francisco Chronicle / Posted 8 days ago
— something that's been referred to as "shadow pricing." At least three companies — Eli Lilly & Co., Novo Nordisk, and Sanofi Aventis — make and sell insulin. Despite this competition, prices have steadily climbed over the past decade, taking... Read more
7 related stories
8d
Business Insider
There's something odd about the way insulin prices change— something that's been referred to as "shadow pricing." At least three compan
There's something odd about the way insulin prices change
Business Insider / Posted 8 days ago
— something that's been referred to as "shadow pricing." At least three companies — Eli Lilly & Co., Novo Nordisk, and Sanofi Aventis — make and sell insulin. Despite this competition, prices have steadily climbed over the past decade, taking... Read more
7 related stories
8d
FOX Business
6 Flu Season Facts You Probably Don't Knowhit later in the season, which could provide for better overall VE on the back-
6 Flu Season Facts You Probably Don't Know
FOX Business / Posted 8 days ago
hit later in the season, which could provide for better overall VE on the back-end of the flu seaason. Image source: Sanofi. The dominant name in the flu vaccine industry is Sanofi(NYSE: SNY). The company's vaccine, known as FluZone, has... Read more
8d
FOX Business
6 Flu Season Facts You Probably Don't Knowhit later in the season, which could provide for better overall VE on the back-
6 Flu Season Facts You Probably Don't Know
FOX Business / Posted 8 days ago
hit later in the season, which could provide for better overall VE on the back-end of the flu seaason. Image source: Sanofi. The dominant name in the flu vaccine industry is Sanofi(NYSE: SNY). The company's vaccine, known as FluZone, has... Read more
9d
Business Standard India
Drug makers go the digital way, arm medical representatives with apps and tabletsroute for product promotion. "It is crucial to customise scientific knowledge
Drug makers go the digital way, arm medical representatives with apps and tablets
Business Standard India / Posted 9 days ago
route for product promotion. "It is crucial to customise scientific knowledge and digital is a great medium to do it. At Sanofi our medical representatives carry iPads which helps them in product detailing. We are also toying with the idea of... Read more
More

People in this news